Featured Research

from universities, journals, and other organizations

Sleep Apnea Likely To Lead To Hypertension

Date:
May 12, 2000
Source:
University Of Wisconsin-Madison
Summary:
Armed with the strongest evidence to date, researchers at the UW Medical School have established that sleep apnea -- episodes of breathing pauses during sleep -- is likely to be an important cause of hypertension.

Armed with the strongest evidence to date, researchers at the UW Medical School have established that sleep apnea -- episodes of breathing pauses during sleep -- is likely to be an important cause of hypertension. Results of their eight-year study involving more than 700 people appear in this week's (May 11) New England Journal of Medicine.

The UW researchers found that even mild to moderate levels of sleep apnea produced a substantial risk of hypertension. And the graver the sleep apnea, the greater the likelihood of developing hypertension, they observed. The new data come form the Wisconsin Sleep Cohort Study (WSCS), an on-going, population-based investigation of cardiopulmonary problems linked to sleep disorders. Funded by the National Heart, Lung and Blood Institute (NHLBI), the WSCS is directed by Dr. Terry Young, UW Medical School professor of preventive medicine.

According to NHLBI Director Dr. Claude Lenfant, "This study dramatically enhances our understanding of the role of sleep apnea in hypertension and provides additional evidence that it may be an independent risk factor for hypertension. Once we have additional follow-up data from the large NHLBI Sleep Heart Health Study, we should be able to make a more reliable determination of the precise role of sleep apnea as a risk factor for cardiovascular disease."

Most previous studies of sleep apnea and hypertension have provided only a cross sectional, or a one-glimpse-in-time, look at the simultaneous occurrence of the two disorders, according to lead author Dr. Paul Peppard of the UW Medical School department of preventive medicine. Some studies have been based on participants' individual reports of snoring, but not on objectively assessed sleep apnea.

"Our findings indicate that sleep apnea might be an important factor in the development of hypertension over time," said Peppard.

In the study, 709 WSCS participants, all randomly selected state employes, were monitored in an overnight stay in a special sleep laboratory at UW Hospital and Clinics' General Clinical Research Center. Researchers measured the number of episodes of breathing pauses each participant had during sleep to determine the presence and severity of sleep apnea. Five to fifteen pauses per hour represented mild to moderate sleep apnea; 15 or more pauses indicated moderate to severe sleep apnea. Participant health was reassessed four years later and in some cases eight years later as well.

The Wisconsin team statistically accounted for other factors related to hypertension--age, gender, weight, menopause, smoking, alcohol use and education--but still found that sleep apnea played a significant and independent role in hypertension risk. People with mild to moderate sleep apnea were twice as likely to become hypertensive; people with moderate to severe sleep apnea were almost three times as likely to become hypertensive.

"These findings tell us that clinicians should take seriously any symptoms or signs of sleep apnea in their patients," said Peppard. "New public health programs may also be important in helping people make lifestyle changes that offer protection against sleep apnea and its consequences."

Earlier findings from the Wisconsin Sleep Cohort Study include: sleep apnea is much more common than previously thought (New England Journal of Medicine, April 27, 1993); smoking puts people at high risk for sleep apnea (Archives of Internal Medicine, Oct. 10, 1994); doctors fail to recognize sleep apnea in women (Archives of Internal Medicine, Dec., 1996); people with undiagnosed sleep apnea may be at greater risk of automobile accidents (Sleep, Aug., 1997).

"We are now studying whether sleep apnea aggravates existing cardiovascular disease and whether modifying the severity of sleep apnea may reduce the risk of hypertension and other health problems," noted Young.


Story Source:

The above story is based on materials provided by University Of Wisconsin-Madison. Note: Materials may be edited for content and length.


Cite This Page:

University Of Wisconsin-Madison. "Sleep Apnea Likely To Lead To Hypertension." ScienceDaily. ScienceDaily, 12 May 2000. <www.sciencedaily.com/releases/2000/05/000512083620.htm>.
University Of Wisconsin-Madison. (2000, May 12). Sleep Apnea Likely To Lead To Hypertension. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2000/05/000512083620.htm
University Of Wisconsin-Madison. "Sleep Apnea Likely To Lead To Hypertension." ScienceDaily. www.sciencedaily.com/releases/2000/05/000512083620.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins